pir-hsa-216911 inhibit pyroptosis in hepatocellular carcinoma by suppressing TLR4 initiated GSDMD activation Liao Zhouxiang Lichao Yang Min He ResearchOpen Access17 Jan 2025Cell Death Discovery Volume: 11, P: 11 Prognostic factors for survival in patients with advanced cholangiocarcinoma treated with percu...
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death, with a 5-year survival rate of <9%18. HCC incidence is closely related to obesity and nonalcoholic fatty liver disease19, and the FAs profile is altered in HCC patients20. The levels of polyunsaturated FAs, ...
PREDICTORS OF SURVIVAL FOR HEPATOCELLULAR CARCINOMA: 2073An abstract is unavailable. This article is available as a PDF only.doi:10.1097/01.tp.0000330772.07685.25Savas, NGokcan, HSezer, RBoyvat, FSelcuk, HYilmaz, UKarakayali, HHaberal, M...
Circular RNAs (circRNAs) are a class of highly stable and closed-loop noncoding RNA that are involved in the occurrence and development of hepatocellular carcinoma (HCC). However, little is known about the therapeutic role of circRNAs in HCC. We found that high circ_0058051 expression was negat...
OBJECTIVE: To evaluate our preliminary experience of high-intensity focused ultrasound (HIFU) for the treatment of recurrent hepatocellular carcinoma (HCC). BACKGROUND: HIFU is a new thermal ablative therapy for HCC. Whether it incurs survival benefit similar to that of radiofrequency ablation (RFA)...
Hepatocellular carcinoma (HCC) is a common type of tumor worldwide. The development of systemic treatment of advanced HCC has remained stagnant for a consi
Effect of triplet regimen (single-agent chemotherapy plus anti-PD-1 antibody and tyrosine kinase inhibitors) on survival compared to chemotherapy in the se... e16132#Background:TOPAZ-1 and KEYNOTE-966 trials have demonstrated the survival benefit of immune checkpoint inhibitors (ICIs) plus ...
The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis EXCLI J, 19 (2020), pp. 108-130 View in ScopusGoogle Scholar 4 Y. Sun, W. Ma, Y. Yang, M. He, A. Li, L. Bai, et al. Cancer nanotechnology: enhancing tumor cell response to ch...
Hepatocellular carcinoma (HCC) is one of the major malignant tumours worldwide1,2. Because it is often diagnosed at an advanced stage, a large proportion of HCC patients displays intrahepatic metastasis or postsurgical recurrence, with a poor 5-year survival rate3. The development of HCC is beli...
As one of the most malignant cancer types, hepatocellular carcinoma (HCC) is highly invasive and capable of metastasizing to distant organs. Intermedin (IMD), an endogenous peptide belonging to the calcitonin family, has been suggested playing important roles in cancer cell survival and invasion, in...